However, the differences in mutation rates in TP53, KRAS, and APC/CTNNB1 between GEJ and gastric carcinomas were not observed within the TCGA cohort, even after comparing mutation frequencies within specific gastric locations. This evidence concerns the gene KRAS and gastric carcinoma.